Genetron Health Announces Receipt Of A Preliminary Non-Binding Proposal From Mr. Sizhen Wang, Co-founder, Chairman Of The Board And Chief Executive Officer Of The Company, To Acquire All Of The Outstanding Ordinary Shares Of The Company For $1.36/ADS
Author: Benzinga Newsdesk | August 22, 2022 06:05am